Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group.
Roehrborn CG, Boyle P, Bergner D, Gray T, Gittelman M, Shown T, Melman A, Bracken RB, deVere White R, Taylor A, Wang D, Waldstreicher J. Roehrborn CG, et al. Among authors: taylor a. Urology. 1999 Oct;54(4):662-9. doi: 10.1016/s0090-4295(99)00232-0. Urology. 1999. PMID: 10510925 Clinical Trial.
Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group.
Roehrborn CG, Bruskewitz R, Nickel GC, Glickman S, Cox C, Anderson R, Kandzari S, Herlihy R, Kornitzer G, Brown BT, Holtgrewe HL, Taylor A, Wang D, Waldstreicher J. Roehrborn CG, et al. Among authors: taylor a. Eur Urol. 2000 May;37(5):528-36. doi: 10.1159/000020189. Eur Urol. 2000. PMID: 10765090 Clinical Trial.
The effect of finasteride in men with benign prostatic hyperplasia. 1992.
Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughan ED, Pappas F, Taylor A, Binkowitz B, Ng J; Finasteride Study Group. Gormley GJ, et al. Among authors: taylor a. J Urol. 2002 Feb;167(2 Pt 2):1102-7; discussion 1108. doi: 10.1016/s0022-5347(02)80349-4. J Urol. 2002. PMID: 11905882 No abstract available.
Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings.
Henick BS, Koch PD, Gainor JF, Awad MM, Chiuzan C, Izard S, Georgis Y, Mallick S, Garofano RF, Wong CV, Saqi A, Grindheim J, Schulze K, Sonett JR, Rizvi NA, Izar B, Taylor AM, Shu CA. Henick BS, et al. Among authors: taylor am. J Immunother Cancer. 2024 Dec 25;12(12):e009301. doi: 10.1136/jitc-2024-009301. J Immunother Cancer. 2024. PMID: 39721753 Free article. Clinical Trial.
Integrating vocational supports into a transition clinic: A pilot program.
Hale EW, Taylor A, Elton M, Honsbruch M, Rosenberg CR, Sanders JS. Hale EW, et al. Among authors: taylor a. Health Care Transit. 2024 Feb 27;2:100048. doi: 10.1016/j.hctj.2024.100048. eCollection 2024. Health Care Transit. 2024. PMID: 39712592 Free PMC article.
DNA methylation-based predictors of metabolic traits in Scottish and Singaporean cohorts.
Smith HM, Ng HK, Moodie JE, Gadd DA, McCartney DL, Bernabeu E, Campbell A, Redmond P, Taylor A, Page D, Corley J, Harris SE, Tay D, Deary IJ, Evans KL, Robinson MR, Chambers JC, Loh M, Cox SR, Marioni RE, Hillary RF. Smith HM, et al. Among authors: taylor a. Am J Hum Genet. 2025 Jan 2;112(1):106-115. doi: 10.1016/j.ajhg.2024.11.012. Epub 2024 Dec 19. Am J Hum Genet. 2025. PMID: 39706196 Free article.
10,407 results
You have reached the last available page of results. Please see the User Guide for more information.